Loading…
Chandra Bhagat Pharma (BSE 542934)₹57.85+4.23%Pharmaceuticals
At the end of the Mar 2026 quarter, Chandra Bhagat Pharma's shareholders were: promoters 73.03%, public 26.97%. Promoter holding is up 0.83 percentage points from 72.20% a quarter earlier. 0.00% of promoter shares were pledged. It had 281 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Promoters | 68.70% | 68.78% | 69.30% | 71.21% | 72.20% | 73.03% |
| FIIs | 1.32% | 1.32% | 0.48% | 0.61% | 0.61% | 0.00% |
| DIIs | 0.90% | 0.90% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 29.08% | 29.00% | 30.22% | 28.18% | 27.19% | 26.97% |
| Promoter shares pledged | — | — | — | — | — | 0.00% |
| Number of shareholders | 135 | 153 | 316 | 317 | 302 | 281 |
| Holder | Category | Mar 2026 | Change (pp) |
|---|---|---|---|
| Hemant Chandravadan Bhagat | Promoter | 35.45% | — |
| Chitra Hemant Bhagat | Promoter | 16.29% | — |
| Pranav Hemant Bhagat | Promoter | 10.16% | — |
| Team Anamika Algo Limited | Public | 7.97% | — |
| Prachi Pranav Bhagat | Promoter | 5.38% | — |
| Hemant C Bhagat Huf | Promoter | 1.99% | — |
| Prashant A Thakkar Huf | Public | 1.65% | — |
| Mahesh C Bhagat | Promoter | 1.58% | — |
| Riddhi Abhinav Chheda | Public | 1.57% | — |
| Multiply Finvest Private Limited | Public | 1.13% | — |
| First Rate Investments Private Limited | Public | 1.12% | — |
| Jay Hemant Bhagat | Promoter | 1.12% | — |
| Khyati Pradeep Joshi | Public | 1.04% | — |
| Padmaben Chandravadan Bhagat | Promoter | 0.53% | — |
| Naynaben Chandravadan Bhagat | Promoter | 0.42% | — |
| Lopa Mahesh Bhagat | Promoter | 0.11% | — |
Promoters held 73.03% of Chandra Bhagat Pharma at the end of the Mar 2026 quarter, up 4.25 percentage points from 68.78% a year earlier.
In the Mar 2026 quarter, foreign institutional investors (FIIs) held 0.00% (down 0.61 percentage points from 0.61% a quarter earlier) and domestic institutions (DIIs) held 0.00% (unchanged at 0.00% a quarter earlier).
No. The Mar 2026 filing shows no pledged promoter shares.
Chandra Bhagat Pharma had 281 shareholders at the end of the Mar 2026 quarter, against 153 a year earlier.
Team Anamika Algo Limited (Public) held 7.97% at the end of the Mar 2026 quarter, the largest named holding outside the promoter group.